Combination of substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for use in treating a hematological malignancy

RS68054B1Active Publication Date: 2026-05-29CELGENE CORP

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: RS · RS
Patent Type: Patents
Current Assignee / Owner: CELGENE CORP
Filing Date: 2020-10-20
Publication Date: 2026-05-29

Application Information

Patent Timeline

20 Oct 2020

Application

29 May 2026

Publication

RS68054B1

IPC: A61K31/4045; A61K31/4184; A61K31/436; A61K31/4468; A61K31/47; A61K31/506; A61K31/519; A61K31/52; A61K31/5377; A61K31/55; A61K31/551; A61K31/635; A61K31/675; A61K31/706; A61K31/7076; A61P35/00

CPC: A61K31/5377; A61K45/06; A61P35/00; A61P35/02; A61K31/47; A61K31/4045; A61K31/635; A61K31/519

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.